Antimalarials

Last updated: September 16, 2025

Antimalarials

Watch later

Watch later

Anxiety disorders: Clinical
Blood products and transfusion: Clinical
Blood groups and transfusions
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Diabetes mellitus: Clinical
Advanced cardiac life support (ACLS): Clinical
Supraventricular arrhythmias: Pathology review
Ventricular arrhythmias: Pathology review
Heart blocks: Pathology review
Coronary artery disease: Clinical
Heart failure: Clinical
Syncope: Clinical
Pericardial disease: Clinical
Valvular heart disease: Clinical
Chest trauma: Clinical
Shock: Clinical
Peripheral vascular disease: Clinical
Leg ulcers: Clinical
Aortic aneurysms and dissections: Clinical
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Sympathomimetics: Direct agonists
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Presynaptic
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
ACE inhibitors, ARBs and direct renin inhibitors
Loop diuretics
Thiazide and thiazide-like diuretics
Calcium channel blockers
cGMP mediated smooth muscle vasodilators
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Positive inotropic medications
Antiplatelet medications
Blistering skin disorders: Clinical
Bites and stings: Clinical
Burns: Clinical
Hyperthyroidism: Clinical
Hypothyroidism and thyroiditis: Clinical
Parathyroid conditions and calcium imbalance: Clinical
Adrenal insufficiency: Clinical
Neck trauma: Clinical
Insulins
Mineralocorticoids and mineralocorticoid antagonists
Glucocorticoids
Abdominal pain: Clinical
Appendicitis: Clinical
Gastrointestinal bleeding: Clinical
Peptic ulcers and stomach cancer: Clinical
Inflammatory bowel disease: Clinical
Diverticular disease: Clinical
Gallbladder disorders: Clinical
Pancreatitis: Clinical
Cirrhosis: Clinical
Hernias: Clinical
Bowel obstruction: Clinical
Abdominal trauma: Clinical
Laxatives and cathartics
Antidiarrheals
Acid reducing medications
Venous thromboembolism: Clinical
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Thrombolytics
Fever of unknown origin: Clinical
Infective endocarditis: Clinical
Pneumonia: Clinical
Tuberculosis: Pathology review
Diarrhea: Clinical
Urinary tract infections: Clinical
Meningitis, encephalitis and brain abscesses: Clinical
Skin and soft tissue infections: Clinical
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Antituberculosis medications
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Herpesvirus medications
Azoles
Echinocandins
Miscellaneous antifungal medications
Anthelmintic medications
Antimalarials
Anti-mite and louse medications
Hypernatremia: Clinical
Hyponatremia: Clinical
Hyperkalemia: Clinical
Hypokalemia: Clinical
Metabolic and respiratory acidosis: Clinical
Metabolic and respiratory alkalosis: Clinical
Toxidromes: Clinical
Medication overdoses and toxicities: Pathology review
Environmental and chemical toxicities: Pathology review
Acute kidney injury: Clinical
Kidney stones: Clinical
Stroke: Clinical
Seizures: Clinical
Headaches: Clinical
Traumatic brain injury: Clinical
Lower back pain: Clinical
Spinal cord disorders: Pathology review
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Migraine medications
Osmotic diuretics
Opioid antagonists
Asthma: Clinical
Chronic obstructive pulmonary disease (COPD): Clinical
Acute respiratory distress syndrome: Clinical
Pleural effusion: Clinical
Pneumothorax: Clinical
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Pulmonary corticosteroids and mast cell inhibitors
Joint pain: Clinical
Anatomy clinical correlates: Clavicle and shoulder
Anatomy clinical correlates: Axilla
Anatomy clinical correlates: Arm, elbow and forearm
Anatomy clinical correlates: Wrist and hand
Anatomy clinical correlates: Median, ulnar and radial nerves
Anatomy clinical correlates: Bones, joints and muscles of the back
Anatomy clinical correlates: Hip, gluteal region and thigh
Anatomy clinical correlates: Knee
Anatomy clinical correlates: Leg and ankle
Anatomy clinical correlates: Foot
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Antigout medications

Transcript

Watch video only

Malaria is an infection that can be caused by a few different types of plasmodium species, which are single-celled parasites that are spread by mosquitoes. There are hundreds of types of Plasmodium species, but the five that cause malarial disease in humans are Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, Plasmodium ovale, and Plasmodium knowlesi. Once the plasmodium gets into the bloodstream, it infects liver cells and red blood cells, which causes a variety of symptoms and sometimes even leads to death. We rely on groups of medications commonly known as antimalarials, in order to prevent and treat malaria.

Now, malaria is transmitted when a plasmodium-infected female of the Anopheles mosquito hunts for a blood meal in the evening and throughout the night. They’re kind of like tiny flying vampires, with the mosquito being drawn to carbon dioxide that gets breathed out, as well as bodily smells, like foot odor. At this point, the Plasmodium is in a stage of development called a sporozoite, waiting patiently in the mosquito’s salivary gland.

When the mosquito bites a person with its proboscis, the worm-like sporozoites spill out of the mosquito’s saliva and make it into the bloodstream. The sporozoites then travel to the liver, where they invade hepatocytes.

There, they begin asexual reproduction, also known as schizogony. Over the next 1-2 weeks, P. falciparum, P. malariae, and P. knowlesi sporozoites multiply asexually and mature into merozoites, while host hepatic parenchymal cells die. In contrast, Plasmodium vivax and Plasmodium ovale sporozoites enter into a dormant hepatic phase, where they are called hypnozoites. They can remain in this dormant phase for months to years until they wake up and begin schizogony.

In both cases, when the merozoites are released into the blood, they enter the erythrocytic phase, where they invade red blood cells. Once inside the red blood cell, Plasmodium feeds on hemoglobin via a process called endocytosis, where the parasite wraps its membrane around the hemoglobin, in order to bring the hemoglobin inside itself. The plasma membrane forms a bubble called a food vacuole where hemoglobin can be broken down. Plasmodium uses the globin proteins to fuel their growth, but the heme is toxic to them, so they are converted into insoluble hemozoin crystals. As the parasite feeds, it undergoes mitosis and differentiates into lots of merozoites, which then burst out of the red blood cell and enter back into circulation.

Now, instead of going into the erythrocytic phase again, some of the merozoites undergo gametogony, which is where they divide and give rise to gametocytes, which are little sausage -shaped sexual forms that can be either male or female. These gametocytes remain inside of a red blood cell, and can get sucked up by another female mosquito that bites the same malaria carrier.

The gametocytes can then fuse together inside the mosquito to form a zygote. This part of the plasmodium life cycle is called sporogony, and it’s sexual reproduction, as opposed to the schizogony or asexual reproduction that happened in the liver and red blood cells. The zygote then goes on to develop further, it becomes an ookinete and then an oocyst that ruptures in the mosquito’s gut, releasing thousands of sporozoites, which navigate their way into the mosquito's salivary gland in order to repeat the cycle all over again.

Symptoms of malaria correspond to the reproductive cycle that is unique for each plasmodium species. When the red blood cells burst at the end of the erythrocytic phase, tumor necrosis factor alpha and other inflammatory cytokines are released, which causes high fevers that typically occur in paroxysms or short bursts.

For example, Plasmodium malariae, fevers happen every 72 hours, and is called quartan fever, while for Plasmodium vivax and Plasmodium ovale, fevers happen every 48 hours, and these are called tertian fever. Now, since red blood cells are destroyed when merozoites are released, malaria also causes hemolytic anemia, with symptoms like extreme fatigue, headaches, jaundice, and splenomegaly.

Now, many of the antimalarial medications are quinoline derivatives like quinine, which is one of the earliest antimalarial medications derived from the bark of South American Cinchona trees. Other medications in this class include quinidine, chloroquine, mefloquine, and primaquine. These medications work by entering the plasmodium and accumulating in their food vacuoles. Here, they bind to heme and prevent it from being converted into hemozoin. Since heme is toxic to the Plasmodium, this eventually leads to their death.

Key Takeaways

Antimalarials are a class of drugs used to treat or prevent malaria. Malaria is caused by parasites belonging to the plasmodium species, and can be deadly if not treated quickly. Antimalarial drugs work by killing these parasites that cause the disease. There are different types of antimalarials usually taken as pills or injections. Common brands include artemisinin, chloroquine, quinine sulfate, doxycycline, and quinine. Antimalarial drugs are effective at treating malaria, but they can have various side effects depending on the drug.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum" Nature Communications (2015)
  5. "Tetracyclines Specifically Target the Apicoplast of the Malaria Parasite Plasmodium falciparum" Antimicrobial Agents and Chemotherapy (2006)